
Jessica Little, MD, is a board-certified infectious diseases physician specializing in transplant and immunocompromised host infectious diseases. She serves as an Attending Physician at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, and is an Instructor in the Department of Medicine at Harvard Medical School. Clinically, Dr. Little focuses on infection management in transplant recipients and other immunocompromised patients, complex opportunistic and drug-resistant infections, and antimicrobial stewardship in high-risk care settings. Her research interests include infectious complications of novel immunosuppressive and cellular therapies, development and evaluation of emerging anti-infective therapeutics and vaccines, and bacteriophage-based approaches for difficult-to-treat infections. In addition to her clinical and academic roles, she a Medical Director of Antimicrobial Stewardship at BWH/DFCI and a frequently invited national speaker on infections in immunocompromised hosts. Dr. Little earned her MD from the University of Virginia School of Medicine, completed residency in Internal Medicine at Brigham and Women’s Hospital, and completed fellowship training in Infectious Diseases/Transplant Infectious Diseases at Brigham and Women’s Hospital and Dana-Farber Cancer Institute.
Attending Physician
Medical School
2013 – 2017
Residency
2017 – 2020
Fellowship
2020 – 2022